GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-22 18:05 |
GENFIT : Résultats de l’Assemblée Générale Mixte du 22 mai 2024
|
French | 102.5 KB | ||
| 2024-05-22 18:05 |
GENFIT: May 22, 2024 Combined Shareholders Meeting Results
|
English | 145.4 KB | ||
| 2024-05-14 22:10 |
GENFIT Reports First Quarter 2024 Financial Information
|
English | 150.8 KB | ||
| 2024-05-14 22:10 |
GENFIT : Information financière du premier trimestre 2024
|
French | 138.9 KB | ||
| 2024-04-25 22:10 |
GENFIT : Publication du rapport de performance extra-financière 2024 (exercice …
|
French | 201.8 KB | ||
| 2024-04-25 22:10 |
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year…
|
English | 201.5 KB | ||
| 2024-04-15 22:10 |
GENFIT : Assemblée Générale Mixte du 22 mai 2024 — modalités de mise à disposit…
|
French | 106.3 KB | ||
| 2024-04-15 22:10 |
GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Prepar…
|
English | 133.8 KB | ||
| 2024-04-05 20:00 |
GENFIT : Mise à disposition du Document d’Enregistrement Universel 2023 et du R…
|
French | 175.0 KB | ||
| 2024-04-05 20:00 |
GENFIT Announces Publication of the 2023 Universal Registration Document and th…
|
English | 174.8 KB | ||
| 2024-04-05 12:05 |
Document d'Enregistrement Universel 2023
|
French | 10.8 MB | ||
| 2024-04-05 12:05 |
Document d'Enregistrement Universel 2023
|
French | 10.8 MB | ||
| 2024-04-04 22:10 |
GENFIT : Résultats financiers annuels 2023 et point sur les activités de la Soc…
|
French | 1.1 MB | ||
| 2024-04-04 22:10 |
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update
|
English | 1.1 MB | ||
| 2024-02-29 22:10 |
GENFIT Announces Revenues and Cash Position as of December 31, 2023
|
English | 176.5 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
